Fig. 4From: A systematic review of health economic models of opioid agonist therapies in maintenance treatment of non-prescription opioid dependenceOverview of outcomes and costs considered. HIV human immunodeficiency virus, LYG life-years gained, QALY quality-adjusted life-yearsBack to article page